Home Coronavirus COVID-19 AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant February 7, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Gen Z Activists Plan New March in Mexico City Protesters Rally Outside the White House in Anti-Trump Demonstration VIDEOS: Young Mexicans Lead Fierce Protests in Mexico City Buen Fin, Mexico’s Annual Shopping Bonanza, Kicks Off Nationwide U.S. Secretary of State Rubio Rules Out Unilateral Military Action in Mexico
